ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
3.20
0.57 (21.67%)
At close: Aug 22, 2025, 3:59 PM
3.22
0.63%
After-hours: Aug 22, 2025, 07:56 PM EDT
ImmunoPrecise Antibodies Balance Sheet Statement
Financials in CAD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Aug 9, 2023 | Apr 30, 2023 | Jan 31, 2023 | Dec 13, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Cash & Equivalents | 10.66M | 12.91M | 3.53M | 3.91M | 3.46M | 6.2M | 6.02M | 19.24M | 8.28M | 11.32M | 15.06M | 19.24M | 29.96M | 32.99M | 38.36M | 40.7M | 41.76M | 15.72M | 16.84M | 6.06M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 137K | 115K | 96K | 89K | 137K | 142K | 105K | 106K | 110K | 111K | 115.85K | 116K | 127.39K |
Other Long-Term Assets | 126K | 90K | 577K | 572K | 86K | 85K | 87K | 81K | 86K | 85K | 86K | 81K | 82K | 81K | 79K | 80K | 79K | 81.27K | 84.01K | 84.46K |
Receivables | 4.81M | 4.87M | 5.04M | 3.19M | 4.07M | 4.48M | 4.68M | 4.63M | 3.88M | 3.26M | 3.98M | 3.73M | 3.41M | 3.46M | 2.9M | 3.54M | 3.63M | 4.44M | 5.45M | 5.47M |
Inventory | 2.1M | 1.92M | 2.01M | 1.87M | 2.14M | 2.53M | 2.45M | 1.55M | 2.06M | 1.81M | 1.58M | 1.55M | 1.61M | 1.53M | 1.28M | 1.29M | 1.2M | 1.23M | 1.12M | 1.02M |
Other Current Assets | n/a | n/a | 267K | 324K | 414K | n/a | 368K | 302K | 536K | n/a | 510K | n/a | n/a | n/a | n/a | n/a | 491K | 625.46K | n/a | n/a |
Total Current Assets | 18.75M | 20.74M | 12.5M | 11.02M | 11.49M | 15.05M | 15.41M | 27.09M | 16.79M | 18.87M | 22.68M | 27.09M | 37.47M | 40.56M | 43.94M | 46.83M | 48.86M | 24.49M | 24M | 12.99M |
Property-Plant & Equipment | 16.26M | 15.71M | 15.96M | 16.44M | 17.17M | 17.03M | 12.24M | 3.48M | 10.72M | 10.79M | 9.95M | 3.48M | 3.71M | 3.73M | 3.82M | 4.14M | 4.08M | 3.59M | 3.62M | 3.65M |
Goodwill & Intangibles | 9.3M | 8.99M | 30.93M | 31.27M | 31.24M | 46.52M | 47.88M | 49.16M | 50.1M | 52.6M | 49.94M | 49.16M | 52.09M | 11.97M | 12.36M | 13.28M | 13.84M | 15.33M | 15.89M | 16.56M |
Total Long-Term Assets | 25.69M | 24.79M | 47.46M | 48.28M | 48.5M | 63.63M | 60.2M | 52.86M | 61.02M | 63.57M | 60.07M | 52.86M | 56.02M | 15.89M | 16.39M | 17.61M | 18.1M | 19.11M | 19.71M | 20.43M |
Total Assets | 44.44M | 45.53M | 59.96M | 59.3M | 59.99M | 78.69M | 75.61M | 79.94M | 77.81M | 82.44M | 82.75M | 79.94M | 93.49M | 56.45M | 60.33M | 64.44M | 66.96M | 43.6M | 43.7M | 33.42M |
Account Payables | 5.28M | 4.39M | 5.38M | 4.52M | 3.52M | 2.98M | 2.15M | 1.95M | 2.48M | 3.5M | 4.28M | 1.53M | 3.92M | 1.71M | 2.77M | 2.98M | 1.34M | 750.33K | 990.48K | 1.56M |
Deferred Revenue | 1.09M | 2.35M | n/a | n/a | 1.35M | 2.02M | 1.61M | 1.39M | 977K | 813K | 1.18M | 1.39M | 1.03M | 983K | 1.29M | 1.26M | 1.11M | 1.73M | 2.33M | 2.33M |
Short-Term Debt | n/a | n/a | 3.09M | 2.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.31M | 1.29M | 1.27M | 1.34M | n/a | n/a | 7.03K | 107.29K |
Other Current Liabilities | 314K | 298K | 2.27M | 2.15M | 2.49M | 2.52M | 2.47M | 728K | 2.32M | 1.06M | 1.84M | 2.26M | 2.17M | 2.57M | 2.12M | n/a | 1.94M | 3.31M | 4.73M | 4.48M |
Total Current Liabilities | 9.01M | 8.93M | 12.41M | 11.17M | 8.12M | 9.09M | 7.53M | 5.36M | 5.92M | 6.65M | 7.31M | 5.36M | 9.26M | 7.14M | 7.53M | 6.62M | 6.07M | 7.23M | 7.84M | 7.6M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.53M | 1.73M | 2.07M | 2.53M |
Other Long-Term Liabilities | n/a | n/a | 3.21M | n/a | n/a | 7.16M | 7.42M | -425K | 7.94M | 8.52M | 8.18M | 8.04M | 8.48M | n/a | n/a | n/a | n/a | n/a | 1.45M | n/a |
Total Long-Term Liabilities | 11.8M | 11.48M | 14.88M | 15.27M | 17.94M | 19.78M | 16.04M | 8.35M | 14.09M | 14.71M | 13.71M | 8.35M | 8.95M | 1.62M | 1.9M | 2.38M | 3.96M | 4.11M | 4.78M | 5.91M |
Total Liabilities | 20.82M | 20.41M | 27.29M | 26.45M | 26.07M | 28.87M | 23.58M | 13.7M | 20.01M | 21.36M | 21.01M | 13.7M | 18.21M | 8.76M | 9.43M | 9M | 10.04M | 11.34M | 12.62M | 13.5M |
Total Debt | 13.4M | 12.93M | 16.42M | 16.1M | 13.68M | 14.39M | 9.57M | 1.12M | 7.27M | 7.47M | 6.68M | 1.12M | 2.55M | 2.81M | 2.93M | 3.29M | 3.46M | 3.67M | 4.27M | 5.02M |
Common Stock | 136.37M | 136.35M | 122.31M | 120.26M | 119.77M | 118.35M | 117.47M | 116.18M | 117.47M | 117.22M | 117.05M | 116.18M | 114.56M | 81.79M | 81.49M | 80.88M | 80.1M | 52.23M | 50.45M | 38.4M |
Retained Earnings | -128.79M | -126.63M | -105.11M | -102.56M | -100.27M | -82.22M | -79.28M | -55.91M | -73.09M | -67.96M | -63.26M | -55.91M | -46.53M | -41.88M | -38.06M | -33.05M | -29.82M | -24.79M | -23.49M | -23.03M |
Comprehensive Income | 3.22M | 2.62M | 2.77M | 2.6M | 2.02M | 1.54M | 1.93M | -4.34M | 2.63M | 1.41M | -2.34M | -4.34M | -2.48M | -1.49M | -1.42M | -801K | -687K | 159.35K | 179.44K | 614.74K |
Shareholders Equity | 23.63M | 25.12M | 32.68M | 32.85M | 33.92M | 49.82M | 52.03M | 66.24M | 57.8M | 61.08M | 61.74M | 66.24M | 75.28M | 47.69M | 50.9M | 55.44M | 56.92M | 32.26M | 31.08M | 19.92M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 137K | 115K | 96K | 89K | 137K | 142K | 105K | 106K | 110K | 111K | 115.85K | 116K | 127.39K |